Karachi: In a recent meeting held on September 23, 2026, the Board of Directors of IBL HealthCare Limited reported a stable financial performance for the fiscal year ending June 30, 2026. Despite the steady results, the board announced that no cash dividends, bonus shares, or right shares would be distributed to shareholders.

According to the statement of financial position, the company's total assets increased slightly to 4.03 billion rupees from 4.01 billion rupees in the previous year. The report highlighted a notable increase in cash and bank balances to 727.18 million rupees, up from 208.94 million rupees, reflecting a significant improvement in liquidity. However, inventories decreased to 884.19 million rupees from 1.27 billion rupees.

The company's equity, including issued, subscribed, and paid-up share capital, rose to 985.26 million rupees from 856.75 million rupees. Revenue reserve, unappropriated profit also saw an increase to 1.44 billion rupees from 1.35 billion rupees.

IBL HealthCare's revenue from contracts with customers rose to 4.61 billion rupees, marking a very large move of 6.58% from 4.32 billion rupees in the previous year. Gross profit also increased to 1.64 billion rupees from 1.45 billion rupees. The company reported a profit before levy and income tax of 401.26 million rupees, growing from 377.09 million rupees. After accounting for income tax expenses of 180.85 million rupees, the profit after taxation amounted to 220.40 million rupees, up from 208.37 million rupees, indicating a moderate move.

According to information available from the Pakistan Stock Exchange (PSX), the financial results reflect a stable trajectory for IBL HealthCare Limited. The company did not announce any corporate actions or price-sensitive information beyond the financial results.

The company's annual report for the fiscal year will be transmitted through PUCARS within the specified time. Despite the stable financial outcomes, the absence of dividend distribution may impact shareholder sentiment in the short term. Nonetheless, IBL HealthCare's financial health remains robust, supported by a strong balance sheet and improved cash flow.